IL15 and central nervous system cancer: Furthermore, the intranasal (i.n.)administration of rAAV2-IL-15 microglia to glioma-bearing mice reaches the tumor mass, with effects on the tumor volume, NK cell recruitment, and M/MΦ phenotype.